CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands |
DSUs
Common Shares
|
DSUs
Additional Paid-in Capital
|
RSUs
Common Shares
|
RSUs
Additional Paid-in Capital
|
Common Shares |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total |
| Balance, beginning at Dec. 31, 2024 |
|
|
|
|
$ 281,552
|
$ 21,298
|
$ 2,742
|
$ (245,170)
|
$ 60,422
|
| Balance, beginning (In shares) at Dec. 31, 2024 |
|
|
|
|
30,039,809
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
(10,724)
|
(10,724)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
103
|
|
103
|
| Vesting of share-based payment award, equity instruments other than options (note 11) |
|
|
$ 89
|
$ (89)
|
|
|
|
|
|
| Vesting of share-based payment award, equity instruments other than options (note 11) (in shares) |
|
|
13,333
|
|
|
|
|
|
|
| Share-based compensation (note 11) |
|
|
|
|
|
989
|
|
|
989
|
| Balance, ending at Mar. 31, 2025 |
|
|
|
|
$ 281,641
|
22,198
|
2,845
|
(255,894)
|
50,790
|
| Balance, ending (in shares) at Mar. 31, 2025 |
|
|
|
|
30,053,142
|
|
|
|
|
| Balance, beginning at Dec. 31, 2024 |
|
|
|
|
$ 281,552
|
21,298
|
2,742
|
(245,170)
|
60,422
|
| Balance, beginning (In shares) at Dec. 31, 2024 |
|
|
|
|
30,039,809
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
|
(34,395)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
|
|
2,008
|
| Balance, ending at Sep. 30, 2025 |
|
|
|
|
$ 282,751
|
24,208
|
4,750
|
(279,566)
|
32,143
|
| Balance, ending (in shares) at Sep. 30, 2025 |
|
|
|
|
30,193,592
|
|
|
|
|
| Balance, beginning at Mar. 31, 2025 |
|
|
|
|
$ 281,641
|
22,198
|
2,845
|
(255,894)
|
50,790
|
| Balance, beginning (In shares) at Mar. 31, 2025 |
|
|
|
|
30,053,142
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
(15,695)
|
(15,695)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
2,713
|
|
2,713
|
| Share-based compensation (note 11) |
|
|
|
|
|
1,451
|
|
|
1,451
|
| Balance, ending at Jun. 30, 2025 |
|
|
|
|
$ 281,641
|
23,649
|
5,558
|
(271,589)
|
39,259
|
| Balance, ending (in shares) at Jun. 30, 2025 |
|
|
|
|
30,053,142
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
(7,977)
|
(7,977)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
(808)
|
|
(808)
|
| Vesting of share-based payment award, equity instruments other than options (note 11) |
$ 74
|
$ (74)
|
$ 1,036
|
(1,036)
|
|
|
|
|
|
| Vesting of share-based payment award, equity instruments other than options (note 11) (in shares) |
8,335
|
|
132,115
|
|
|
|
|
|
|
| Share-based compensation (note 11) |
|
|
|
|
|
1,669
|
|
|
1,669
|
| Balance, ending at Sep. 30, 2025 |
|
|
|
|
$ 282,751
|
24,208
|
4,750
|
(279,566)
|
32,143
|
| Balance, ending (in shares) at Sep. 30, 2025 |
|
|
|
|
30,193,592
|
|
|
|
|
| Balance, beginning at Dec. 31, 2025 |
|
|
|
|
$ 323,839
|
25,310
|
5,025
|
(287,740)
|
$ 66,434
|
| Balance, beginning (In shares) at Dec. 31, 2025 |
|
|
|
|
36,293,640
|
|
|
|
36,293,640
|
| Net loss for the period |
|
|
|
|
|
|
|
(7,053)
|
$ (7,053)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
(1,005)
|
|
(1,005)
|
| Vesting of share-based payment award, equity instruments other than options (note 11) |
$ 68
|
(68)
|
$ 256
|
(256)
|
|
|
|
|
|
| Vesting of share-based payment award, equity instruments other than options (note 11) (in shares) |
10,000
|
|
33,997
|
|
|
|
|
|
|
| Share-based compensation (note 11) |
|
|
|
|
|
1,048
|
|
|
1,048
|
| Balance, ending at Mar. 31, 2026 |
|
|
|
|
$ 324,163
|
26,034
|
4,020
|
(294,793)
|
59,424
|
| Balance, ending (in shares) at Mar. 31, 2026 |
|
|
|
|
36,337,637
|
|
|
|
|
| Balance, beginning at Dec. 31, 2025 |
|
|
|
|
$ 323,839
|
25,310
|
5,025
|
(287,740)
|
$ 66,434
|
| Balance, beginning (In shares) at Dec. 31, 2025 |
|
|
|
|
36,293,640
|
|
|
|
36,293,640
|
| Net loss for the period |
|
|
|
|
|
|
|
|
$ (24,315)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
|
|
$ (1,821)
|
| Exercise of share options (note 11) (in shares) |
|
|
|
|
|
|
|
|
7,749
|
| Balance, ending at Sep. 30, 2026 |
|
|
|
|
$ 326,108
|
25,256
|
3,204
|
(312,055)
|
$ 42,513
|
| Balance, ending (in shares) at Sep. 30, 2026 |
|
|
|
|
36,626,844
|
|
|
|
36,626,844
|
| Balance, beginning at Mar. 31, 2026 |
|
|
|
|
$ 324,163
|
26,034
|
4,020
|
(294,793)
|
$ 59,424
|
| Balance, beginning (In shares) at Mar. 31, 2026 |
|
|
|
|
36,337,637
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
(9,540)
|
(9,540)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
(950)
|
|
(950)
|
| Vesting of share-based payment award, equity instruments other than options (note 11) |
$ 96
|
(96)
|
$ 1,124
|
(1,124)
|
|
|
|
|
|
| Vesting of share-based payment award, equity instruments other than options (note 11) (in shares) |
16,128
|
|
178,829
|
|
|
|
|
|
|
| Share-based compensation (note 11) |
|
|
|
|
|
874
|
|
|
874
|
| Balance, ending at Jun. 30, 2026 |
|
|
|
|
$ 325,383
|
25,688
|
3,070
|
(304,333)
|
49,808
|
| Balance, ending (in shares) at Jun. 30, 2026 |
|
|
|
|
36,532,594
|
|
|
|
|
| Net loss for the period |
|
|
|
|
|
|
|
(7,722)
|
(7,722)
|
| Cumulative translation adjustment - net of tax of $nil |
|
|
|
|
|
|
134
|
|
134
|
| Vesting of share-based payment award, equity instruments other than options (note 11) |
$ 58
|
$ (58)
|
$ 612
|
$ (612)
|
|
|
|
|
|
| Vesting of share-based payment award, equity instruments other than options (note 11) (in shares) |
6,668
|
|
79,833
|
|
|
|
|
|
|
| Exercise of share options (note 11) |
|
|
|
|
$ 55
|
(19)
|
|
|
36
|
| Exercise of share options (note 11) (in shares) |
|
|
|
|
7,749
|
|
|
|
|
| Share-based compensation (note 11) |
|
|
|
|
|
257
|
|
|
257
|
| Balance, ending at Sep. 30, 2026 |
|
|
|
|
$ 326,108
|
$ 25,256
|
$ 3,204
|
$ (312,055)
|
$ 42,513
|
| Balance, ending (in shares) at Sep. 30, 2026 |
|
|
|
|
36,626,844
|
|
|
|
36,626,844
|